Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
709 (USA) · Dr. Novak
consented 2012-12-01
AEs
4
Serious
0
Dropout signal
–
Adverse events
mild
assessed
Mild ABDOMINAL PAIN — outcome: RECOVERED/RESOLVED; onset 2013-01-03 (study day 34.0); relationship: POSSIBLE
mild
assessed
Mild APPLICATION SITE DERMATITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-12-27 (study day 27.0); relationship: PROBABLE
mild
assessed
Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-01-15 (study day 46.0); relationship: PROBABLE
mild
assessed
Mild DIARRHOEA — outcome: RECOVERED/RESOLVED; onset 2013-01-03 (study day 34.0); relationship: POSSIBLE
Data queries
No data queries.